These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32783399)

  • 1. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
    Chen H; Ma X; Yang M; Wang M; Li L; Huang T
    Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
    Wang T; Tian K; Ji X; Song F
    Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
    Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
    Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning.
    Zhou B; Liu J; Yang Y; Ye X; Liu Y; Mao M; Sun X; Cui X; Zhou Q
    BMC Cancer; 2024 Jul; 24(1):810. PubMed ID: 38972977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma.
    Zhu X; Ma X; Wu C
    Math Biosci Eng; 2021 Oct; 18(6):8559-8576. PubMed ID: 34814313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
    He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
    Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma.
    Tang J; Jiang S; Gao Q; Xi X; Gao L; Zhao R; Lai X; Zhang B; Jiang Y
    Cancer Med; 2021 Aug; 10(16):5488-5498. PubMed ID: 34240816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
    Ruiz EML; Niu T; Zerfaoui M; Kunnimalaiyaan M; Friedlander PL; Abdel-Mageed AB; Kandil E
    Surgery; 2020 Jan; 167(1):73-79. PubMed ID: 31711617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
    Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
    Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.
    Shi J; Huang D; Zhang G; Zhao F; Yang L
    Medicine (Baltimore); 2020 Dec; 99(51):e23772. PubMed ID: 33371144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
    Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
    Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
    Zhang Y; Lu H; Zhang J; Wang S
    Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
    Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
    Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.
    Tang H; Kan L; Ou T; Chen D; Dou X; Wu W; Ji X; Wang M; Zong Z; Mo H; Zhang X; Xiong D
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
    Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
    Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
    Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.